173 related articles for article (PubMed ID: 26345532)
1. Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice.
Seo JW; Kim YG; Lee SH; Lee A; Kim DJ; Jeong KH; Lee KH; Hwang SJ; Woo JS; Lim SJ; Kim W; Moon JY
Biomed Res Int; 2015; 2015():301627. PubMed ID: 26345532
[TBL] [Abstract][Full Text] [Related]
2. Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression.
Kim SM; Lee SH; Lee A; Kim DJ; Kim YG; Kim SY; Jeong KH; Lee TW; Ihm CG; Lim SJ; Moon JY
Transl Res; 2015 Oct; 166(4):375-83. PubMed ID: 26001596
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.
Utimura R; Fujihara CK; Mattar AL; Malheiros DM; Noronha IL; Zatz R
Kidney Int; 2003 Jan; 63(1):209-16. PubMed ID: 12472785
[TBL] [Abstract][Full Text] [Related]
4. Renal injury induced in alloxan diabetic rats. Role of Mycophenolate Mofetil as therapeutic agent.
Elseweidy MM; Elswefy SE; Ali AE; Shawky M
Pathol Res Pract; 2014 Dec; 210(12):979-84. PubMed ID: 24939145
[TBL] [Abstract][Full Text] [Related]
5. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
[TBL] [Abstract][Full Text] [Related]
6. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy.
Wu Y; Dong J; Yuan L; Liang C; Ren K; Zhang W; Fang F; Shen J
Cytokine; 2008 Oct; 44(1):85-91. PubMed ID: 18725182
[TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes.
Arellano-Buendía AS; Tostado-González M; García-Arroyo FE; Cristóbal-García M; Loredo-Mendoza ML; Tapia E; Sánchez-Lozada LG; Osorio-Alonso H
Oxid Med Cell Longev; 2016; 2016():4693801. PubMed ID: 26955430
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats.
Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z
Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907
[TBL] [Abstract][Full Text] [Related]
9. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
11. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
12. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats.
Wu X; Zha D; Xiang G; Zhang B; Xiao SY; Jia R
Cytokine; 2006 Dec; 36(5-6):229-36. PubMed ID: 17337203
[TBL] [Abstract][Full Text] [Related]
13. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines.
Mensah-Brown EP; Obineche EN; Galadari S; Chandranath E; Shahin A; Ahmed I; Patel SM; Adem A
Cytokine; 2005 Aug; 31(3):180-90. PubMed ID: 15975818
[TBL] [Abstract][Full Text] [Related]
17. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
[TBL] [Abstract][Full Text] [Related]
18. [Effect of mycophenolate mofetil on the expression of early inflammatory reaction in diabetic rats].
Peng L; Zhang H; Xu G; Tang RH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):913-8. PubMed ID: 19001733
[TBL] [Abstract][Full Text] [Related]
19. Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling.
Lu M; Yin N; Liu W; Cui X; Chen S; Wang E
Biomed Res Int; 2017; 2017():1516985. PubMed ID: 28194406
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice.
Pei F; Li BY; Zhang Z; Yu F; Li XL; Lu WD; Cai Q; Gao HQ; Shen L
J Diabetes Complications; 2014; 28(5):596-603. PubMed ID: 24927646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
